• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

CCT241736

CAS No. 1402709-93-6

CCT241736 ( CCT241736; CCT-241736; CCT 241736 )

产品货号. M17277 CAS No. 1402709-93-6

CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.

纯度: 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥446 有现货
10MG ¥721 有现货
25MG ¥1450 有现货
50MG ¥2811 有现货
100MG ¥4204 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    CCT241736
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.
  • 产品描述
    CCT241736 is a potent and orally active and dual FLT3-Aurora inhibitor. CCT241736 has IC50 values against FLT3, Aurora A and Aurora B of 0.035, 0.015 and 0.1 μM respectively. CCT241736 inhibits a wide range of FLT3 mutants, including FLT3-ITD, -D835Y, -D835H, -K663Q and -N841I. In cellular assays, CCT241736 inhibits viability of the human FLT3-ITD positive AML cell lines MOLM-13 and MV-4;11 with EC50 values of 0.1 and 0.27
  • 同义词
    CCT241736; CCT-241736; CCT 241736
  • 通路
    GPCR/G Protein
  • 靶点
    Dopamine Receptor
  • 受体
    FLT3;Aurora Kinase
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1402709-93-6
  • 分子量
    456.37
  • 分子式
    C22H23Cl2N7
  • 纯度
    98%
  • 溶解度
    DMSO : 75 mg/mL 164.34 mM; H2O : < 0.1 mg/mL
  • SMILES
    Cc5nn(C)cc5c3nc4ncc(Cl)c(N2CCN(Cc1ccc(Cl)cc1)CC2)c4n3
  • 化学全称
    6-chloro-7-[4-[(4-chlorophenyl)methyl]-1-piperazinyl]-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Bavetsias V,etal. J Med Chem. 2012 Oct 25;55(20):8721-34.
产品手册
关联产品
  • E6446

    E6446 inhibits Toll-like receptor (TLR)7 and 9 signaling. E6446 works in a variety of human and mouse cell types and inhibits DNA-TLR9 interaction in vitro.

  • NMI 8739

    NMI 8739 is an agonist of D2 autoreceptor. NMI 8739 reduces NO production and elicits concentration-dependent suppression of CCL-20, MCP-1 and IL-6 release.

  • FIIN-2

    FIIN-2, an irreversible, pan-FGFR inhibitor, inhibits FGFR1/2/3/4 with IC50 of 3.09 nM, 4.3 nM, 27 nM and 45.3 nM, respectively.